← ANALYSTS · TIPRANKS
Asad Haider · Goldman Sachs
Hits
82%
45 of 55 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+22.7%
Over a year after the rating, TipRanks’ measure
Our companies rated now
11
Buy / hold / sell: 5 / 5 / 1
Upside of the analyst’s targets
+15.7%
Average over 11 current targets, to the last price
The market’s answer to the ratings
+2.2%
Day-0 move against SPY in the rating’s direction, average over 7 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 13on TipRanks Oct 14 09:35 | BNTXBioNTech SE · $24.1B | Reiterated | Buy | $127 | +44.8% | −7.1%next day +0.7% | ↗ |
| Oct 12on TipRanks Oct 13 09:45 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Hold | $61.00 → $63.00+3.3% | +5.4% | −2.5%next day −1.6% | ↗ |
| Oct 6on TipRanks Oct 7 08:31 | PCVXIWMVaxcyte · $10.3B | Reiterated | Hold | $67.00 → $85.00+26.9% | +33.6% | −10.2%next day +0.6% · 5 days +0.3% | ↗ |
| Sep 30on TipRanks Oct 1 09:45 | LLYSPYEli Lilly & Co · $1.2T | Reiterated | Buy | $1,367 → $1,371+0.3% | +9.1% | −2.1%next day −0.8% · 5 days +0.8% | ↗ |
| Sep 30on TipRanks Oct 1 09:35 | MRKSPYMerck & Company · $358B | Reiterated | Buy | $160 | +9.6% | −2.5%next day −1.2% · 5 days −3.6% | ↗ |
| Sep 14on TipRanks Sep 15 09:35 | BNTXBioNTech SE · $24.1B | Reiterated | Buy | $127 | +44.8% | +2.6%next day −1.7% · 5 days −2.8% | ↗ |
| Aug 25on TipRanks Aug 26 04:55 | JNJSPYJohnson & Johnson · $610B | Reiterated | Buy | $282 | +10.3% | +0.2%next day −1.2% · 5 days −0.2% | ↗ |
| Aug 20on TipRanks Aug 19 12:55 | MRKSPYMerck & Company · $358B | Reiterated | Buy | $140 → $160+14.3% | +9.6% | +12.4%next day −1.3% · 5 days +1.0% | ↗ |
| Aug 6on TipRanks 09:50 | LLYSPYEli Lilly & Co · $1.2T | Reiterated | Buy | $1,283 → $1,367+6.5% | +8.7% | +2.0%next day −1.1% · 5 days +0.2% | ↗ |
| Aug 6on TipRanks 07:55 | RPRXRoyalty Pharma · $32.7B | Reiterated | Buy | $59.00 → $66.00+11.9% | +8.3% | −0.7%next day −1.5% · 5 days +1.1% | ↗ |
| Aug 4on TipRanks Aug 5 05:05 | PFESPYPfizer · $168B | Reiterated | Hold | $26.00 | −12.1% | −0.3%next day +1.8% · 5 days +4.9% | ↗ |
| Jul 21on TipRanks Jul 24 05:15 | ABBVSPYAbbVie · $501B | Reiterated | Hold | $244 | −14.5% | +0.2%next day −1.0% · 5 days +3.8% | ↗ |
| Jul 20on TipRanks Jul 23 21:17 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Hold | $61.00 | +2.1% | −0.8%next day +0.4% · 5 days +4.4% | ↗ |
| May 7on TipRanks May 11 09:10 | NAMSNewAmsterdam Pharma Company · $2.4B | Reiterated | Hold | $37.00 → $38.00+2.7% | +91.6% | +12.8%next day +10.3% · 5 days +3.6% | ↗ |
| May 6on TipRanks May 7 07:15 | INVAIWMInnoviva · $1.5B | Reiterated | Sell | $18.00 | −13.4% | −2.0%next day +1.6% · 5 days +1.6% | ↗ |
| Feb 26on TipRanks Feb 25 08:10 | PCVXIWMVaxcyte · $10.3B | Reiterated | Hold | $38.00 → $67.00+76.3% | +5.3% | +1.9%next day −4.3% · 5 days −3.5% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗